Barrier Factors of Adherence to Dupilumab Self-Injection for Severe Allergic Disease: A Non-Interventional Open-Label Study

Barrier Factors of Adherence to Dupilumab Self-Injection for Severe Allergic Disease: A Non-Interventional Open-Label Study

Kei Hosoya,1 Taro Komachi,2,* Katsunori Masaki,3,* Isao Suzaki,4 Hidehisa Saeki,5 Naoko Kanda,6 Makoto Nozaki,7 Yosuke Kamide,8 Yoshinori Matsuwaki,9 Yoshiki Kobayashi,10 Eriko Ogino,11 Shin-Ichi Osada,12 Norihiro Usukura,13 Toshikazu Kurumagawa,14 Junya Ninomia,15 Mikiya Asako,16 Ke...

Full description

Bibliographic Details
Main Authors: Hosoya K, Komachi T, Masaki K, Suzaki I, Saeki H, Kanda N, Nozaki M, Kamide Y, Matsuwaki Y, Kobayashi Y, Ogino E, Osada SI, Usukura N, Kurumagawa T, Ninomia J, Asako M, Nakamoto K, Yokoi H, Ohyama M, Tanese K, Kanzaki S, Fukunaga K, Ebisawa M, Okubo K
Format: Article
Language:English
Published: Dove Medical Press 2023-03-01
Series:Patient Preference and Adherence
Subjects:
atopic dermatitis
biologics
bronchial asthma
chronic rhinosinusitis
Online Access:https://www.dovepress.com/barrier-factors-of-adherence-to-dupilumab-self-injection-for-severe-al-peer-reviewed-fulltext-article-PPA

Internet

https://www.dovepress.com/barrier-factors-of-adherence-to-dupilumab-self-injection-for-severe-al-peer-reviewed-fulltext-article-PPA

Similar Items